Results 31 to 40 of about 8,386 (180)

Distribution of adult T‐cell leukaemia/lymphoma subtypes and survival outcomes across geographical regions: An international retrospective cohort study

open access: yesBritish Journal of Haematology, Volume 209, Issue 1, Page 107-115, July 2026.
Summary Although adult T‐cell leukaemia/lymphoma (ATL) has a higher burden in certain world regions, outcomes have not been directly compared across regions. We conducted a multicentre cohort study comparing the distribution of ATL subtypes and overall survival (OS) across 1090 adults (≥18 years) diagnosed with ATL during 2000–2023 in Japan (n = 366 ...
Bryan Valcarcel   +31 more
wiley   +1 more source

Linfoadenopatia transitória secundária à síndrome nefrótica

open access: yesArquivos Brasileiros de Cardiologia, 2012
Linfadenomegalias mediastinais secundárias a hipervolemia são achados tomográficos subdiagnosticados. Descrevemos neste paciente com função cardíaca normal, achados de congestão pulmonar associados a alargamento dos linfonodos mediastinais.
Olívia Meira Dias   +3 more
doaj   +1 more source

Linfoma de Burkitt axilar

open access: yesGalicia Clínica, 2021
Varón de 50 años con diagnóstico de infección por VIH desde Junio 2018 estadio A3 a tratamiento con dolutegravir/abacavir/lamivudina con carga viral indetectable desde inicio de tratamiento y niveles de CD4 superiores a 1.000/mm3 que acude por cuadro ...
Sonia María Morón Losada   +1 more
doaj   +1 more source

Glomerulonefritis colapsante con marcadores de desdiferenciación podocitaria en síndrome hemofagocítico secundario a linfoma hepatoesplénico de células T

open access: yesBiomédica: revista del Instituto Nacional de Salud, 2018
El síndrome hemofagocítico es una condición clínica e histológica grave, secundaria a diferentes procesos. La glomerulonefritis colapsante es una podocitopatía proliferativa, generalmente de pronóstico desfavorable para la función renal.
María Adoración Martín-Gómez   +6 more
doaj   +1 more source

Exploring Resistance to ETS Targeting Agents in Diffuse Large B‐Cell Lymphoma

open access: yesCancer Medicine, Volume 15, Issue 5, May 2026.
This study provides the first systematic characterization of resistance to ETS inhibition in diffuse large B‐cell lymphoma (DLBCL). Using TK216‐resistant models, we reveal heterogeneous escape mechanisms, including MDR1 upregulation, transcriptional reprogramming, and cytoskeletal remodeling, each associated with distinct mutational signatures ...
Filippo Spriano   +9 more
wiley   +1 more source

Linfoma angioinmunoblástico de células T [PDF]

open access: yesGalicia Clínica, 2016
Se trata de un linfoma muy agresivo, con una mediana de supervivencia en torno a los 3 años. En cuanto al tratamiento, se han ensayado varias modalidades terapéuticas entre las cuales se encuentran los corticoides, los fármacos citotóxicos (vorinostat ...
Gargantilla P, Martin BM, Pintor E
doaj   +1 more source

Assessing patient perspectives on enrollment in lymphoma clinical trials

open access: yesCancer, Volume 132, Issue 8, 15 April 2026.
Abstract Background Clinical trials drive advances in lymphoma care, yet certain patient groups including socioeconomically disadvantaged, racial/ethnic groups, and women remain underrepresented. Given limited/inconsistent data regarding solutions to improve clinical trial enrollment of these groups, the authors performed a study to assess patient ...
Neha Akkad   +14 more
wiley   +1 more source

Signos neurológicos asociados a pacientes caninos con linfoma

open access: yesRevista de Medicina Veterinaria, 2012
El cáncer altera las estructuras o las funciones de órganos vecinos por su simple presencia, con las consiguientes manifestaciones clínicas; pero también produce efectos nocivos en órganos distantes. Estas alteraciones clínicas inducidas por la acción no
Adriana Patricia Suraniti   +9 more
doaj   +1 more source

Preinfusion risk factors for the development of severe neurotoxicity following CART therapy in pediatric patients

open access: yesHemaSphere, Volume 10, Issue 4, April 2026.
Abstract Neurotoxicity is a common and potentially life‐threatening complication after chimeric antigen receptor T‐cell therapy (CART) for pediatric B‐cell acute lymphoblastic leukemia (B‐ALL). The only consistently demonstrated clinical risk factor for severe neurotoxicity in prior studies is high, preinfusion bone marrow disease burden (DB).
Caroline Diorio   +18 more
wiley   +1 more source

PERFIL DOS PACIENTES COM CÂNCER NO SANGUE QUE BUSCAM PELO SERVIÇO DA PSICOLOGIA DE UMA ASSOCIAÇÃO SOCIAL ESPECIALIZADA DE SÃO PAULO - RELATO DE EXPERIÊNCIA

open access: yesHematology, Transfusion and Cell Therapy
Introdução: O contexto oncológico traz a necessidade de uma assistência multiprofissional e diversas intervenções de cuidado em toda a jornada de tratamento, Esta jornada,em específico do câncer no sangue, afeta as bases de segurança.
LT Ferri, RC Pires
doaj   +1 more source

Home - About - Disclaimer - Privacy